Medical Developments International Limited Medical Developments International Limited

Medical Developments International Limited

MVP

Rang in aandelen #27376
Medical Developments International Limited (MDIL) specializes in the... Medical Developments International Limited (MDIL) specializes in the development and provision of essential emergency medical solutions, serving global markets including Australia, Europe, and the United States. The company's operations are divided into two primary segments: Pain Management and Respiratory care. Among its key offerings is Penthrox, a product specifically formulated for rapid pain relief in acute trauma and emergency situations. Within the respiratory segment, MDIL supplies equipment designed to assist individuals with conditions like asthma and chronic obstructive pulmonary disease (COPD). Additionally, its comprehensive portfolio features a diverse array of medical devices, encompassing items such as CPR face shields and masks, finger pulse oximeters, flow meter regulators, MDI tourniquets, manually triggered ventilators, oxygen resuscitation kits, and various oxygen therapy and resuscitation apparatus. Established in 2003, the company maintains its headquarters in Scoresby, Australia.
Aandeelprijs
$0.28211392
Marktkapitalisatie
$31.78M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
-12.00%
Land
AU
Handel Medical Developments International Limited (MVP)

Categorie

Healthcare
EPS voor Medical Developments International Limited (MVP)
EPS per 2026 TTM: 0
Volgens de laatste financiële rapporten en de aandelenkoers van Medical Developments International Limited is de huidige EPS van het bedrijf (TTM) 0. Eind 2026 had het bedrijf een EPS van 0, gelijk aan de EPS van 2026 die 0 bedroeg.
EPS-geschiedenis van Medical Developments International Limited van 2026 tot 2026
EPS aan het einde van elk jaar
Jaar EPS Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
EPS van vergelijkbare bedrijven of concurrenten